{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:48:27Z","timestamp":1769010507064,"version":"3.49.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00393-021-01063-7","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:05:52Z","timestamp":1628611552000},"page":"335-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rescued from desperation: adult-onset Still\u2019s disease with life-threatening interstitial lung disease and macrophage activation","Aus der Verzweiflung gerettet: Morbus Still des Erwachsenen mit lebensbedrohlicher interstitieller Pneumonie und Makrophagenaktivierungssyndrom"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-0765","authenticated-orcid":false,"given":"Guangfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"1063_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist\u00a0E, Mitrovic\u00a0S, Fautrel\u00a0B (2018) Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol 14:603\u2013618","journal-title":"Nat Rev Rheumatol"},{"key":"1063_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","volume":"93","author":"R Giacomelli","year":"2018","unstructured":"Giacomelli\u00a0R, Ruscitti\u00a0P, Shoenfeld\u00a0Y (2018) A comprehensive review on adult onset Still\u2019s disease. J\u00a0Autoimmun 93:24\u201336","journal-title":"J Autoimmun"},{"key":"1063_CR3","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/14712598.2019.1652591","volume":"19","author":"DH Yoo","year":"2019","unstructured":"Yoo\u00a0DH (2019) Biologics for the treatment of adult-onset still\u2019s disease. Expert Opin Biol Ther 19:1173\u20131190","journal-title":"Expert Opin Biol Ther"},{"key":"1063_CR4","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1136\/annrheumdis-2018-213920","volume":"77","author":"Y Kaneko","year":"2018","unstructured":"Kaneko\u00a0Y, Kameda\u00a0H, Ikeda\u00a0K, Ishii\u00a0T, Murakami\u00a0K, Takamatsu\u00a0H, Tanaka\u00a0Y, Abe\u00a0T, Takeuchi\u00a0T (2018) Tocilizumab in patients with adult-onset still\u2019s disease refractory to glucocorticoid treatment: a\u00a0randomised, double-blind, placebo-controlled phase III trial. Ann Rheum Dis 77:1720\u20131729","journal-title":"Ann Rheum Dis"},{"key":"1063_CR5","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi\u00a0M, Ohta\u00a0A, Tsunematsu\u00a0T, Kasukawa\u00a0R, Mizushima\u00a0Y, Kashiwagi\u00a0H, Kashiwazaki\u00a0S, Tanimoto\u00a0K, Matsumoto\u00a0Y, Ota\u00a0T, Et\u00a0A (1992) Preliminary criteria for classification of adult Still\u2019s disease. J\u00a0Rheumatol 19:424\u2013430","journal-title":"J Rheumatol"},{"key":"1063_CR6","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1136\/ard.2005.046904","volume":"65","author":"JB Arlet","year":"2006","unstructured":"Arlet\u00a0JB, Le\u00a0TH, Marinho\u00a0A, Amoura\u00a0Z, Wechsler\u00a0B, Papo\u00a0T, Piette\u00a0JC (2006) Reactive haemophagocytic syndrome in adult-onset Still\u2019s disease: a\u00a0report of six patients and a\u00a0review of the literature. Ann Rheum Dis 65:1596\u20131601","journal-title":"Ann Rheum Dis"},{"key":"1063_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter\u00a0JI, Horne\u00a0A, Arico\u00a0M, Egeler\u00a0RM, Filipovich\u00a0AH, Imashuku\u00a0S, Ladisch\u00a0S, McClain\u00a0K, Webb\u00a0D, Winiarski\u00a0J, Janka\u00a0G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"1063_CR8","first-page":"23","volume":"121","author":"Y Takakuwa","year":"2019","unstructured":"Takakuwa\u00a0Y, Hanaoka\u00a0H, Kiyokawa\u00a0T, Iida\u00a0H, Ishimori\u00a0K, Uekusa\u00a0T, Yamada\u00a0H, Kawahata\u00a0K (2019) Adult-onset Still\u2019s disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse. Clin Exp Rheumatol 37 Suppl 121(6):23\u201327","journal-title":"Clin Exp Rheumatol 37 Suppl"},{"key":"1063_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/1744666X.2018.1533403","volume":"14","author":"P Ruscitti","year":"2018","unstructured":"Ruscitti\u00a0P, Giacomelli\u00a0R (2018) Pathogenesis of adult onset still\u2019s disease: current understanding and new insights. Expert Rev Clin Immunol 14:965\u2013976","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01063-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-021-01063-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01063-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T11:08:37Z","timestamp":1651489717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-021-01063-7"}},"subtitle":["Successful treatment by Tocilizumab","Erfolgreiche Therapie durch Tocilizumab"],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1007\/s00393-021-01063-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"assertion":[{"value":"14 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"G.\u00a0Zhang, W.\u00a0Liu, X.\u00a0Zhang, and L.\u00a0Liu declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case. Additional written informed consent was obtained from all individual participants or their legal representatives for whom identifying information is included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}